However, Demaria et al. [6] reported that co-administration of an anti-CTLA4 mAb with RT of 4T1 mouse breast cancer both enhanced the therapeutic effect of irradiated local tumors and suppressed metastasis. This evidence concerns the gene CTLA4 and breast carcinoma.